1Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes[J]. N Engl J Med,2003,348(12) : 1104-1111. 被引量：1
2Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J]. N Engl J Med, 2002,347(20) : 1557-1565. 被引量：1
4Bottazzi B, Vouret-Craviari V, Bastone A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3: similarities and differences with the short pentraxins C-reactive protein and serum amyloid P eomponent[J]. J Biol Chem, 1997, 272(52) :32817-32823. 被引量：1
5Basile A, Sica A, d'Aniello E, et al. Characterization of the promoter for the human long pentraxin PTX3. Rote of NF-kappaB in tumor necrosis factor-alpha and interleukin-lbeta regulation[J]. J Biol Chem, 1997,272(13) : 8172- 8178. 被引量：1
6Rolph MS, Zimmer S, Bottazzi B, et al. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques [ J ]. Arterioscler Thromb Vase Biol,2002,22(5)..e10-e14. 被引量：1
7Napoleone E,di Santo A,Peri G,et al. The long pentraxin PTX3 up-regulates tissue factor in activated monoeytes: another link between inflammation and dotting aetivation[J]. J Leukoe Biol, 2004,76(1) :203-209. 被引量：1
8Rusnati M,Camozzi M,Moroni E, et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis[J]. Blood,2004,104(1) :92-99. 被引量：1
二级参考文献14
1GENSINI G G.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(9):606-607. 被引量：1
2RIDKER P M,CUSHMAN M,STAMPTER M J,et al.Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease[J].Circulation,1999,197(7):425-428. 被引量：1
3EMEST E.Fibrinogen as a cardiovascular risk factor:interrelationship with infections and inflammation[J].Eur Heart J,1994,14(2):82-83. 被引量：1
4KOHCHIK E,TAKEBAYASHIS J G,HIROKIT M.Significance of adventitial inflammation of the coronary artery in patients with unstable angina:results at autopsy[J].Circulation,1985,71(10):709. 被引量：1
5HEINRICH J.Association of variables of coagulation,fibrinolysis and acute phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain[J].Thromb Haemostas,1995,73(6):374-378. 被引量：1
6TORZEWSKI J,TORZEWSKI M,BOWYER D E,et al.C-reactive protein frequently colocalizes with the terminal complement complex in the intimate of early atherosclerotive lesions of human coronary arteries[J].Arterioscler Thromb Vasc Biol,1998,18(11):1386-1392. 被引量：1
7WOODWARD M,LOWE G D,RUMLEY A,et al.Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women[J].Eur Heart J,1998,19(1):55-62. 被引量：1
8LEVERSON J,GIRAL P,RAZVIAN M,et al.Fibrinogen and silent atherosclerosis in subject swith cardiovascular risk factors [J].Arterioscler Thfromb Vasc Biol,1995,15(10):1263-1268. 被引量：1
9MINNO G D,MANCINI M.Measuring plasma fibrinogen to predict stroke and myocardial infarction [J].Atheriosclerosis,1990,10(1):1-7. 被引量：1
10HANDA K,KONO S,SAKU K,et al.Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis[J].Atherosclerosis,1998,77(4):209-213. 被引量：1
